The Cost-Utility of Fidaxomicin as Compared to Current Standard Treatment in the Management of Clostridium Difficile Infections in Belgium
Abstract
Authors
M. Lamotte K. Vellopoulou K. Richir J. Smets K. Grabe K. Coppens
M. Lamotte K. Vellopoulou K. Richir J. Smets K. Grabe K. Coppens
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now